RU2016146567A - Способ дифференцировки плюрипотентных стволовых клеток в кардиомиоциты - Google Patents

Способ дифференцировки плюрипотентных стволовых клеток в кардиомиоциты Download PDF

Info

Publication number
RU2016146567A
RU2016146567A RU2016146567A RU2016146567A RU2016146567A RU 2016146567 A RU2016146567 A RU 2016146567A RU 2016146567 A RU2016146567 A RU 2016146567A RU 2016146567 A RU2016146567 A RU 2016146567A RU 2016146567 A RU2016146567 A RU 2016146567A
Authority
RU
Russia
Prior art keywords
cells
pluripotent stem
paragraphs
insulin
cardiomyocytes
Prior art date
Application number
RU2016146567A
Other languages
English (en)
Russian (ru)
Other versions
RU2016146567A3 (zh
Inventor
Марк БЮРСЕН
Зонья ШЛИХТ
Original Assignee
Ф. Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф. Хоффманн-Ля Рош Аг filed Critical Ф. Хоффманн-Ля Рош Аг
Publication of RU2016146567A publication Critical patent/RU2016146567A/ru
Publication of RU2016146567A3 publication Critical patent/RU2016146567A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
RU2016146567A 2014-05-06 2015-05-04 Способ дифференцировки плюрипотентных стволовых клеток в кардиомиоциты RU2016146567A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14167201.4 2014-05-06
EP14167201 2014-05-06
PCT/EP2015/059745 WO2015169762A1 (en) 2014-05-06 2015-05-04 Method for differentiation of pluripotent stem cells into cardiomyocytes

Publications (2)

Publication Number Publication Date
RU2016146567A true RU2016146567A (ru) 2018-06-08
RU2016146567A3 RU2016146567A3 (zh) 2018-12-10

Family

ID=50679891

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016146567A RU2016146567A (ru) 2014-05-06 2015-05-04 Способ дифференцировки плюрипотентных стволовых клеток в кардиомиоциты

Country Status (10)

Country Link
US (1) US10155927B2 (zh)
EP (1) EP3140395B1 (zh)
JP (1) JP6744223B2 (zh)
KR (1) KR20160147800A (zh)
CN (1) CN106661553B (zh)
BR (1) BR112016023818A2 (zh)
CA (1) CA2943035A1 (zh)
MX (1) MX2016014008A (zh)
RU (1) RU2016146567A (zh)
WO (1) WO2015169762A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107475185A (zh) * 2016-06-07 2017-12-15 杨旅军 一种用于培养人间充质干细胞的无动物源成分培养基
JP7298844B2 (ja) * 2017-06-05 2023-06-27 テルモ株式会社 細胞培養物の製造方法
AU2020288888A1 (en) 2019-06-06 2022-01-27 President And Fellows Of Harvard College Cardiomyocytes and compositions and methods for producing the same
CN115135754A (zh) * 2020-02-28 2022-09-30 普渡研究基金会 在限定条件下从人多能干细胞生成主动脉-性腺-中肾样造血细胞
CN113249310B (zh) * 2021-05-17 2022-10-11 湖北大学 一种拓展性多能干细胞诱导分化为心肌细胞的方法及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2540135C (en) * 2003-10-03 2012-12-04 Keiichi Fukuda Method of inducing the differentiation of stem cells into cardiomyocytes
US20080254003A1 (en) * 2004-12-22 2008-10-16 Robert Passier Differentiation of Human Embryonic Stem Cells and Cardiomyocytes and Cardiomyocyte Progenitors Derived Therefrom
KR101529317B1 (ko) * 2005-06-22 2015-06-16 아스테리아스 바이오세라퓨틱스, 인크. 영장류 다능성 줄기 세포의 심근세포 계통 세포로의 분화
UA103918C2 (en) * 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
EP4166652A1 (en) * 2009-11-12 2023-04-19 Technion Research & Development Foundation Ltd. Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
WO2012026491A1 (ja) * 2010-08-26 2012-03-01 国立大学法人京都大学 多能性幹細胞の心筋分化促進剤
CA2836843A1 (en) * 2011-06-09 2012-12-13 F. Hoffmann-La Roche Ag Method for differentiation of pluripotent stem cells into vascular bed cells
WO2013056072A1 (en) * 2011-10-13 2013-04-18 Wisconsin Alumni Research Foundation Generation of cardiomyocytes from human pluripotent stem cells
JP6494515B2 (ja) * 2012-10-19 2019-04-03 エージェンシー フォー サイエンス， テクノロジー アンド リサーチ 幹細胞を１又は２以上の細胞系列に分化させる方法

Also Published As

Publication number Publication date
KR20160147800A (ko) 2016-12-23
EP3140395B1 (en) 2020-01-22
CN106661553A (zh) 2017-05-10
US20150353893A1 (en) 2015-12-10
US10155927B2 (en) 2018-12-18
BR112016023818A2 (pt) 2017-08-15
JP2017518739A (ja) 2017-07-13
CN106661553B (zh) 2020-09-01
JP6744223B2 (ja) 2020-08-19
MX2016014008A (es) 2017-01-11
CA2943035A1 (en) 2015-11-12
WO2015169762A1 (en) 2015-11-12
EP3140395A1 (en) 2017-03-15
RU2016146567A3 (zh) 2018-12-10

Similar Documents

Publication Publication Date Title
RU2016146567A (ru) Способ дифференцировки плюрипотентных стволовых клеток в кардиомиоциты
IL307568A (en) Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
JP2015061520A5 (zh)
RU2016149540A (ru) Способы очистки клеток, производных от плюрипотентных стволовых клеток
MX2016016251A (es) Expansion de linfocitos con composicion de citocinas para inmunoterapia celular activa.
BRPI0813729B8 (pt) métodos de preparação de massas celulares de cardiomiócitos purificados derivados de células-tronco pluripotentes e de uma película de massas celulares de cardiomiócitos, bem como dispositivo médico e uso das referidas massas celulares
EP4275760A3 (en) Egg protein formulations and methods of manufacture thereof
EA201591817A1 (ru) Не содержащая сыворотки среда для культивирования клеток
BR112014010455A2 (pt) Métodos para produzir um anticorpo, usos de il-e2 e/ou il-21, métodos para cultivar uma célula, usos de uma célula de mamífero e uso de sac no co- cultivo de células b
IN2014MN01981A (zh)
EA201401225A1 (ru) F-меченые аналоги фолата/антифолата
BR112018012070A2 (pt) método para a produção de tecidos/ órgãos utilizando células sanguíneas
CA2837895C (en) Methods of treating or preventing neurological diseases
SG11201806843UA (en) Method for producing activated hepatocyte growth factor (hgf)
RU2012144595A (ru) Способ получения культуры симбиотических бактерий энтомопатогенных нематод
JP2008501795A5 (zh)
WO2015097665A8 (en) Method for the isolation, purification and amplification of renal progenitors cd133+cd24+ from the urine of patients suffering from renal diseases
CN204070160U (zh) 一种鱼苗锻炼网箱
Kim et al. PRINCIPLES OF EAST PHILOSOPHY IN THERAPY OF ADDICTION
AR110634A1 (es) Método para preparar un suplemento a partir de cultivos de células mesenquimales de gelatina de wharton y usos del mismo
Dashkovskiy et al. THE NOMADIC ELITE OF XIONGNU: ANALYSIS OF THE
RU2013151490A (ru) Способ синхронизации клеточного цикла фибробластов, выделенных из кожи человека, на стадии g0/g1
Gavrilova et al. INCREASING THE TOTAL CONCENTRATION OF EXTRACELLULAR DNA LEADS TO DEVELOPMENT OF AUTOIMMUNE PATHOLOGY IN EXPERFMENTAL MODEL OF SYSTEMIC LUPUS ERYTHEMATOSUS
Savkin PROSPECTS FOR BONE MARROW HEMATOPOIETIC CELLS USING IN THE TREATMENT OF CHRONIC HEPATIC INSUFFICIENCY
Ershova EFFICIENCY OF CREATIVE ACTIVITY AS A METHOD OF SELF-REALIZATION OF A TEACHER

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20190327